A Midtown-based diagnostics company raised capital in a deal to advance its novel approach to screening for the risk factors ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

New indication for Tevimbra in combination with platinum-containing chemotherapy as a first-line treatment addresses an unmet ...

Researchers at Case Western Reserve University (CWRU) and University Hospitals (UH) will use state-of-the-art medical ...

BeiGene (ONC) has received FDA approval for Tevimbra for first-line esophageal cancer with chemo. Read more here.

The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...

BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1 ...

Study finds Mediterranean diet reduces cancer risks linked to obesity, especially for colorectal, liver and kidney cancers, ...

Medically reviewed by Qin Rao, MD Barrett's esophagus occurs when the lining of the esophagus, the tube that runs from the ...

The goal is to reduce the incidence of esophageal cancer (EAC). EAC is a rare type of cancer with a high-morality rate-the cause of 2.6% of all cancer deaths nationally-and is more common in men ...